Feasibility of Telemedicine Medical Abortion

TelAbortion: Medical Abortion by Direct-to-patient Telemedicine and Mail

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04599725

Enrollment

413

Registered

2020-10-23

Start date

2020-10-01

Completion date

2021-10-01

Last updated

2022-02-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy

Brief summary

This pilot study is designed to obtain data on the safety, acceptability, and feasibility of providing abortion by direct-to-patient telemedicine and mail.

Interventions

DRUGmedical abortion

medical abortion

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

10 Years to 50 Years

Healthy volunteers

Yes

Inclusion criteria

* desires abortion

Exclusion criteria

* medically ineligible for procedure

Design outcomes

Primary

Measure	Time frame
Number of participants with adverse events	2 years

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026